nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—Aminohippurate—Balsalazide—ulcerative colitis	0.259	1	CrCrCtD
Procainamide—SLC22A4—ulcerative colitis	0.223	0.571	CbGaD
Procainamide—SLC22A5—ulcerative colitis	0.168	0.429	CbGaD
Procainamide—SLC22A4—Nicotine—ulcerative colitis	0.0576	0.236	CbGbCtD
Procainamide—SLC22A3—Nicotine—ulcerative colitis	0.0524	0.215	CbGbCtD
Procainamide—SLC22A5—Nicotine—ulcerative colitis	0.0326	0.134	CbGbCtD
Procainamide—SLC22A2—Nicotine—ulcerative colitis	0.031	0.127	CbGbCtD
Procainamide—SLC22A1—Nicotine—ulcerative colitis	0.027	0.111	CbGbCtD
Procainamide—BCHE—Triamcinolone—ulcerative colitis	0.0253	0.104	CbGbCtD
Procainamide—CYP2D6—Nicotine—ulcerative colitis	0.00779	0.0319	CbGbCtD
Procainamide—CYP2D6—Cholecalciferol—ulcerative colitis	0.00698	0.0286	CbGbCtD
Procainamide—CYP2D6—Dexamethasone—ulcerative colitis	0.00302	0.0124	CbGbCtD
Procainamide—Cinchocaine—CALM3—ulcerative colitis	0.000994	0.321	CrCbGaD
Procainamide—Sunitinib—JAK2—ulcerative colitis	0.000459	0.148	CrCbGaD
Procainamide—Aminohippurate—SLC22A4—ulcerative colitis	0.000371	0.12	CrCbGaD
Procainamide—Probenecid—SLC22A5—ulcerative colitis	0.000282	0.0911	CrCbGaD
Procainamide—Aminohippurate—SLC22A5—ulcerative colitis	0.000279	0.0899	CrCbGaD
Procainamide—Lidocaine—SLC22A5—ulcerative colitis	0.000271	0.0876	CrCbGaD
Procainamide—Psychotic disorder—Methylprednisolone—ulcerative colitis	0.000166	0.00313	CcSEcCtD
Procainamide—Abdominal pain upper—Hydrocortisone—ulcerative colitis	0.000165	0.00312	CcSEcCtD
Procainamide—Hypersensitivity—Nicotine—ulcerative colitis	0.000164	0.0031	CcSEcCtD
Procainamide—Cardiac disorder—Mesalazine—ulcerative colitis	0.000163	0.00308	CcSEcCtD
Procainamide—Cardiac arrest—Triamcinolone—ulcerative colitis	0.000162	0.00306	CcSEcCtD
Procainamide—Cardiac arrest—Methylprednisolone—ulcerative colitis	0.000161	0.00305	CcSEcCtD
Procainamide—Myalgia—Budesonide—ulcerative colitis	0.00016	0.00303	CcSEcCtD
Procainamide—Arthralgia—Budesonide—ulcerative colitis	0.00016	0.00303	CcSEcCtD
Procainamide—Asthenia—Nicotine—ulcerative colitis	0.00016	0.00302	CcSEcCtD
Procainamide—Discomfort—Budesonide—ulcerative colitis	0.000158	0.00299	CcSEcCtD
Procainamide—Cardiac failure—Dexamethasone—ulcerative colitis	0.000158	0.00299	CcSEcCtD
Procainamide—Cardiac failure—Betamethasone—ulcerative colitis	0.000158	0.00299	CcSEcCtD
Procainamide—Pruritus—Nicotine—ulcerative colitis	0.000158	0.00298	CcSEcCtD
Procainamide—Chills—Mesalazine—ulcerative colitis	0.000158	0.00298	CcSEcCtD
Procainamide—Lethargy—Betamethasone—ulcerative colitis	0.000157	0.00298	CcSEcCtD
Procainamide—Lethargy—Dexamethasone—ulcerative colitis	0.000157	0.00298	CcSEcCtD
Procainamide—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000157	0.00297	CcSEcCtD
Procainamide—Ill-defined disorder—Azathioprine—ulcerative colitis	0.000156	0.00294	CcSEcCtD
Procainamide—Confusional state—Budesonide—ulcerative colitis	0.000155	0.00293	CcSEcCtD
Procainamide—Diarrhoea—Nicotine—ulcerative colitis	0.000152	0.00288	CcSEcCtD
Procainamide—Malaise—Azathioprine—ulcerative colitis	0.000151	0.00286	CcSEcCtD
Procainamide—Shock—Budesonide—ulcerative colitis	0.000151	0.00285	CcSEcCtD
Procainamide—Psychotic disorder—Betamethasone—ulcerative colitis	0.000151	0.00285	CcSEcCtD
Procainamide—Psychotic disorder—Dexamethasone—ulcerative colitis	0.000151	0.00285	CcSEcCtD
Procainamide—Dysgeusia—Mesalazine—ulcerative colitis	0.00015	0.00283	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Budesonide—ulcerative colitis	0.000149	0.0771	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Budesonide—ulcerative colitis	0.000149	0.0771	CbGdCrCtD
Procainamide—Dizziness—Nicotine—ulcerative colitis	0.000147	0.00279	CcSEcCtD
Procainamide—Cardiac arrest—Dexamethasone—ulcerative colitis	0.000147	0.00277	CcSEcCtD
Procainamide—Cardiac arrest—Betamethasone—ulcerative colitis	0.000147	0.00277	CcSEcCtD
Procainamide—Anorexia—Budesonide—ulcerative colitis	0.000146	0.00277	CcSEcCtD
Procainamide—Vomiting—Mercaptopurine—ulcerative colitis	0.000146	0.00276	CcSEcCtD
Procainamide—Myalgia—Azathioprine—ulcerative colitis	0.000143	0.0027	CcSEcCtD
Procainamide—Arthralgia—Azathioprine—ulcerative colitis	0.000143	0.0027	CcSEcCtD
Procainamide—Ill-defined disorder—Mesalazine—ulcerative colitis	0.000142	0.00268	CcSEcCtD
Procainamide—Vomiting—Nicotine—ulcerative colitis	0.000142	0.00268	CcSEcCtD
Procainamide—Discomfort—Azathioprine—ulcerative colitis	0.000141	0.00267	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.00014	0.00264	CcSEcCtD
Procainamide—Angioedema—Mesalazine—ulcerative colitis	0.00014	0.00264	CcSEcCtD
Procainamide—Malaise—Mesalazine—ulcerative colitis	0.000138	0.00261	CcSEcCtD
Procainamide—Cardiac failure—Prednisone—ulcerative colitis	0.000138	0.0026	CcSEcCtD
Procainamide—Lethargy—Prednisone—ulcerative colitis	0.000137	0.00259	CcSEcCtD
Procainamide—Nausea—Mercaptopurine—ulcerative colitis	0.000137	0.00258	CcSEcCtD
Procainamide—Thrombocytopenia—Azathioprine—ulcerative colitis	0.000134	0.00254	CcSEcCtD
Procainamide—Decreased appetite—Budesonide—ulcerative colitis	0.000133	0.00252	CcSEcCtD
Procainamide—Nausea—Nicotine—ulcerative colitis	0.000132	0.0025	CcSEcCtD
Procainamide—Psychotic disorder—Prednisone—ulcerative colitis	0.000131	0.00248	CcSEcCtD
Procainamide—Bradycardia—Prednisolone—ulcerative colitis	0.00013	0.00246	CcSEcCtD
Procainamide—Arthralgia—Mesalazine—ulcerative colitis	0.00013	0.00246	CcSEcCtD
Procainamide—Myalgia—Mesalazine—ulcerative colitis	0.00013	0.00246	CcSEcCtD
Procainamide—Discomfort—Mesalazine—ulcerative colitis	0.000129	0.00243	CcSEcCtD
Procainamide—Hypotension—Azathioprine—ulcerative colitis	0.000128	0.00242	CcSEcCtD
Procainamide—Cardiac arrest—Prednisone—ulcerative colitis	0.000128	0.00241	CcSEcCtD
Procainamide—Bradycardia—Hydrocortisone—ulcerative colitis	0.000127	0.0024	CcSEcCtD
Procainamide—Feeling abnormal—Budesonide—ulcerative colitis	0.000126	0.00239	CcSEcCtD
Procainamide—Confusional state—Mesalazine—ulcerative colitis	0.000126	0.00238	CcSEcCtD
Procainamide—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000125	0.00237	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000125	0.00236	CcSEcCtD
Procainamide—DNMT1—Budesonide—Hydrocortisone—ulcerative colitis	0.000125	0.0645	CbGdCrCtD
Procainamide—Hallucination—Hydrocortisone—ulcerative colitis	0.000124	0.00235	CcSEcCtD
Procainamide—Shock—Mesalazine—ulcerative colitis	0.000123	0.00232	CcSEcCtD
Procainamide—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000122	0.00231	CcSEcCtD
Procainamide—Urticaria—Budesonide—ulcerative colitis	0.000122	0.0023	CcSEcCtD
Procainamide—Abdominal pain—Budesonide—ulcerative colitis	0.000121	0.00229	CcSEcCtD
Procainamide—Body temperature increased—Budesonide—ulcerative colitis	0.000121	0.00229	CcSEcCtD
Procainamide—Bradycardia—Triamcinolone—ulcerative colitis	0.00012	0.00226	CcSEcCtD
Procainamide—Bradycardia—Methylprednisolone—ulcerative colitis	0.000119	0.00226	CcSEcCtD
Procainamide—Anorexia—Mesalazine—ulcerative colitis	0.000119	0.00225	CcSEcCtD
Procainamide—DNMT1—Budesonide—Methylprednisolone—ulcerative colitis	0.000118	0.0608	CbGdCrCtD
Procainamide—Hallucination—Methylprednisolone—ulcerative colitis	0.000117	0.00221	CcSEcCtD
Procainamide—Hypotension—Mesalazine—ulcerative colitis	0.000117	0.0022	CcSEcCtD
Procainamide—DNMT1—Budesonide—Betamethasone—ulcerative colitis	0.000116	0.0599	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Dexamethasone—ulcerative colitis	0.000116	0.0599	CbGdCrCtD
Procainamide—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000114	0.00215	CcSEcCtD
Procainamide—DNMT1—Budesonide—Triamcinolone—ulcerative colitis	0.000113	0.0585	CbGdCrCtD
Procainamide—Hypersensitivity—Budesonide—ulcerative colitis	0.000113	0.00214	CcSEcCtD
Procainamide—Feeling abnormal—Azathioprine—ulcerative colitis	0.000113	0.00213	CcSEcCtD
Procainamide—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000112	0.00212	CcSEcCtD
Procainamide—Asthenia—Budesonide—ulcerative colitis	0.00011	0.00208	CcSEcCtD
Procainamide—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000109	0.00206	CcSEcCtD
Procainamide—Bradycardia—Dexamethasone—ulcerative colitis	0.000109	0.00205	CcSEcCtD
Procainamide—Bradycardia—Betamethasone—ulcerative colitis	0.000109	0.00205	CcSEcCtD
Procainamide—Neutropenia—Prednisone—ulcerative colitis	0.000109	0.00205	CcSEcCtD
Procainamide—Pruritus—Budesonide—ulcerative colitis	0.000109	0.00205	CcSEcCtD
Procainamide—Decreased appetite—Mesalazine—ulcerative colitis	0.000108	0.00205	CcSEcCtD
Procainamide—Body temperature increased—Azathioprine—ulcerative colitis	0.000108	0.00205	CcSEcCtD
Procainamide—Abdominal pain—Azathioprine—ulcerative colitis	0.000108	0.00205	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisone—ulcerative colitis	0.000107	0.0555	CbGdCrCtD
Procainamide—Hallucination—Betamethasone—ulcerative colitis	0.000106	0.00201	CcSEcCtD
Procainamide—Hallucination—Dexamethasone—ulcerative colitis	0.000106	0.00201	CcSEcCtD
Procainamide—Diarrhoea—Budesonide—ulcerative colitis	0.000105	0.00198	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisolone—ulcerative colitis	0.000105	0.0542	CbGdCrCtD
Procainamide—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000103	0.00195	CcSEcCtD
Procainamide—Depression—Prednisone—ulcerative colitis	0.000103	0.00195	CcSEcCtD
Procainamide—Feeling abnormal—Mesalazine—ulcerative colitis	0.000103	0.00194	CcSEcCtD
Procainamide—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000102	0.00193	CcSEcCtD
Procainamide—Angioedema—Prednisolone—ulcerative colitis	0.000102	0.00192	CcSEcCtD
Procainamide—Dizziness—Budesonide—ulcerative colitis	0.000101	0.00192	CcSEcCtD
Procainamide—Hypersensitivity—Azathioprine—ulcerative colitis	0.000101	0.00191	CcSEcCtD
Procainamide—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000101	0.00191	CcSEcCtD
Procainamide—Malaise—Prednisolone—ulcerative colitis	0.0001	0.0019	CcSEcCtD
Procainamide—Dysgeusia—Triamcinolone—ulcerative colitis	0.0001	0.0019	CcSEcCtD
Procainamide—Angioedema—Hydrocortisone—ulcerative colitis	9.94e-05	0.00188	CcSEcCtD
Procainamide—Urticaria—Mesalazine—ulcerative colitis	9.92e-05	0.00187	CcSEcCtD
Procainamide—Abdominal pain—Mesalazine—ulcerative colitis	9.87e-05	0.00186	CcSEcCtD
Procainamide—Body temperature increased—Mesalazine—ulcerative colitis	9.87e-05	0.00186	CcSEcCtD
Procainamide—Malaise—Hydrocortisone—ulcerative colitis	9.81e-05	0.00185	CcSEcCtD
Procainamide—Vomiting—Budesonide—ulcerative colitis	9.76e-05	0.00184	CcSEcCtD
Procainamide—Convulsion—Prednisolone—ulcerative colitis	9.65e-05	0.00182	CcSEcCtD
Procainamide—Ill-defined disorder—Triamcinolone—ulcerative colitis	9.5e-05	0.0018	CcSEcCtD
Procainamide—Ill-defined disorder—Methylprednisolone—ulcerative colitis	9.48e-05	0.00179	CcSEcCtD
Procainamide—Bradycardia—Prednisone—ulcerative colitis	9.46e-05	0.00179	CcSEcCtD
Procainamide—Convulsion—Hydrocortisone—ulcerative colitis	9.42e-05	0.00178	CcSEcCtD
Procainamide—Diarrhoea—Azathioprine—ulcerative colitis	9.38e-05	0.00177	CcSEcCtD
Procainamide—Discomfort—Prednisolone—ulcerative colitis	9.37e-05	0.00177	CcSEcCtD
Procainamide—Angioedema—Triamcinolone—ulcerative colitis	9.36e-05	0.00177	CcSEcCtD
Procainamide—Angioedema—Methylprednisolone—ulcerative colitis	9.34e-05	0.00176	CcSEcCtD
Procainamide—Myalgia—Hydrocortisone—ulcerative colitis	9.26e-05	0.00175	CcSEcCtD
Procainamide—Hallucination—Prednisone—ulcerative colitis	9.25e-05	0.00175	CcSEcCtD
Procainamide—Malaise—Triamcinolone—ulcerative colitis	9.23e-05	0.00175	CcSEcCtD
Procainamide—Malaise—Methylprednisolone—ulcerative colitis	9.21e-05	0.00174	CcSEcCtD
Procainamide—Hypersensitivity—Mesalazine—ulcerative colitis	9.2e-05	0.00174	CcSEcCtD
Procainamide—Discomfort—Hydrocortisone—ulcerative colitis	9.15e-05	0.00173	CcSEcCtD
Procainamide—Nausea—Budesonide—ulcerative colitis	9.12e-05	0.00172	CcSEcCtD
Procainamide—Dizziness—Azathioprine—ulcerative colitis	9.06e-05	0.00171	CcSEcCtD
Procainamide—Asthenia—Mesalazine—ulcerative colitis	8.96e-05	0.00169	CcSEcCtD
Procainamide—Shock—Prednisolone—ulcerative colitis	8.94e-05	0.00169	CcSEcCtD
Procainamide—Convulsion—Triamcinolone—ulcerative colitis	8.87e-05	0.00168	CcSEcCtD
Procainamide—Convulsion—Methylprednisolone—ulcerative colitis	8.85e-05	0.00167	CcSEcCtD
Procainamide—Pruritus—Mesalazine—ulcerative colitis	8.83e-05	0.00167	CcSEcCtD
Procainamide—Benzocaine—ABCB1—ulcerative colitis	8.81e-05	0.0284	CrCbGaD
Procainamide—Shock—Hydrocortisone—ulcerative colitis	8.73e-05	0.00165	CcSEcCtD
Procainamide—Myalgia—Triamcinolone—ulcerative colitis	8.72e-05	0.00165	CcSEcCtD
Procainamide—Vomiting—Azathioprine—ulcerative colitis	8.71e-05	0.00165	CcSEcCtD
Procainamide—Myalgia—Methylprednisolone—ulcerative colitis	8.7e-05	0.00164	CcSEcCtD
Procainamide—Arthralgia—Methylprednisolone—ulcerative colitis	8.7e-05	0.00164	CcSEcCtD
Procainamide—Flushing—Prednisone—ulcerative colitis	8.63e-05	0.00163	CcSEcCtD
Procainamide—Ill-defined disorder—Dexamethasone—ulcerative colitis	8.62e-05	0.00163	CcSEcCtD
Procainamide—Ill-defined disorder—Betamethasone—ulcerative colitis	8.62e-05	0.00163	CcSEcCtD
Procainamide—Discomfort—Triamcinolone—ulcerative colitis	8.61e-05	0.00163	CcSEcCtD
Procainamide—Discomfort—Methylprednisolone—ulcerative colitis	8.59e-05	0.00162	CcSEcCtD
Procainamide—Diarrhoea—Mesalazine—ulcerative colitis	8.54e-05	0.00161	CcSEcCtD
Procainamide—Angioedema—Dexamethasone—ulcerative colitis	8.49e-05	0.0016	CcSEcCtD
Procainamide—Angioedema—Betamethasone—ulcerative colitis	8.49e-05	0.0016	CcSEcCtD
Procainamide—Anorexia—Hydrocortisone—ulcerative colitis	8.46e-05	0.0016	CcSEcCtD
Procainamide—Confusional state—Methylprednisolone—ulcerative colitis	8.41e-05	0.00159	CcSEcCtD
Procainamide—Malaise—Betamethasone—ulcerative colitis	8.38e-05	0.00158	CcSEcCtD
Procainamide—Malaise—Dexamethasone—ulcerative colitis	8.38e-05	0.00158	CcSEcCtD
Procainamide—Hypotension—Hydrocortisone—ulcerative colitis	8.29e-05	0.00157	CcSEcCtD
Procainamide—Dizziness—Mesalazine—ulcerative colitis	8.25e-05	0.00156	CcSEcCtD
Procainamide—Shock—Triamcinolone—ulcerative colitis	8.22e-05	0.00155	CcSEcCtD
Procainamide—Shock—Methylprednisolone—ulcerative colitis	8.2e-05	0.00155	CcSEcCtD
Procainamide—Nausea—Azathioprine—ulcerative colitis	8.14e-05	0.00154	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	8.09e-05	0.00153	CcSEcCtD
Procainamide—Convulsion—Dexamethasone—ulcerative colitis	8.05e-05	0.00152	CcSEcCtD
Procainamide—Convulsion—Betamethasone—ulcerative colitis	8.05e-05	0.00152	CcSEcCtD
Procainamide—Vomiting—Mesalazine—ulcerative colitis	7.94e-05	0.0015	CcSEcCtD
Procainamide—Myalgia—Betamethasone—ulcerative colitis	7.91e-05	0.0015	CcSEcCtD
Procainamide—Myalgia—Dexamethasone—ulcerative colitis	7.91e-05	0.0015	CcSEcCtD
Procainamide—Probenecid—ALB—ulcerative colitis	7.83e-05	0.0253	CrCbGaD
Procainamide—Discomfort—Betamethasone—ulcerative colitis	7.82e-05	0.00148	CcSEcCtD
Procainamide—Discomfort—Dexamethasone—ulcerative colitis	7.82e-05	0.00148	CcSEcCtD
Procainamide—Hypotension—Methylprednisolone—ulcerative colitis	7.79e-05	0.00147	CcSEcCtD
Procainamide—Decreased appetite—Hydrocortisone—ulcerative colitis	7.72e-05	0.00146	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Hydrocortisone—ulcerative colitis	7.63e-05	0.0394	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Hydrocortisone—ulcerative colitis	7.63e-05	0.0394	CbGdCrCtD
Procainamide—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	7.61e-05	0.00144	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	7.6e-05	0.00144	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisone—ulcerative colitis	7.51e-05	0.00142	CcSEcCtD
Procainamide—Feeling abnormal—Prednisolone—ulcerative colitis	7.49e-05	0.00142	CcSEcCtD
Procainamide—Probenecid—ABCB1—ulcerative colitis	7.47e-05	0.0241	CrCbGaD
Procainamide—Shock—Dexamethasone—ulcerative colitis	7.46e-05	0.00141	CcSEcCtD
Procainamide—Shock—Betamethasone—ulcerative colitis	7.46e-05	0.00141	CcSEcCtD
Procainamide—Thrombocytopenia—Betamethasone—ulcerative colitis	7.42e-05	0.0014	CcSEcCtD
Procainamide—Thrombocytopenia—Dexamethasone—ulcerative colitis	7.42e-05	0.0014	CcSEcCtD
Procainamide—Nausea—Mesalazine—ulcerative colitis	7.41e-05	0.0014	CcSEcCtD
Procainamide—Angioedema—Prednisone—ulcerative colitis	7.39e-05	0.0014	CcSEcCtD
Procainamide—Aminohippurate—ABCB1—ulcerative colitis	7.37e-05	0.0238	CrCbGaD
Procainamide—Feeling abnormal—Hydrocortisone—ulcerative colitis	7.31e-05	0.00138	CcSEcCtD
Procainamide—Malaise—Prednisone—ulcerative colitis	7.3e-05	0.00138	CcSEcCtD
Procainamide—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	7.26e-05	0.00137	CcSEcCtD
Procainamide—Anorexia—Dexamethasone—ulcerative colitis	7.23e-05	0.00137	CcSEcCtD
Procainamide—Anorexia—Betamethasone—ulcerative colitis	7.23e-05	0.00137	CcSEcCtD
Procainamide—Urticaria—Prednisolone—ulcerative colitis	7.22e-05	0.00136	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Methylprednisolone—ulcerative colitis	7.2e-05	0.0372	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Methylprednisolone—ulcerative colitis	7.2e-05	0.0372	CbGdCrCtD
Procainamide—Lidocaine—ABCB1—ulcerative colitis	7.18e-05	0.0232	CrCbGaD
Procainamide—DNMT1—Betamethasone—Dexamethasone—ulcerative colitis	7.09e-05	0.0366	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Betamethasone—ulcerative colitis	7.09e-05	0.0366	CbGdCrCtD
Procainamide—Hypotension—Dexamethasone—ulcerative colitis	7.09e-05	0.00134	CcSEcCtD
Procainamide—Hypotension—Betamethasone—ulcerative colitis	7.09e-05	0.00134	CcSEcCtD
Procainamide—Urticaria—Hydrocortisone—ulcerative colitis	7.05e-05	0.00133	CcSEcCtD
Procainamide—Body temperature increased—Hydrocortisone—ulcerative colitis	7.02e-05	0.00133	CcSEcCtD
Procainamide—Abdominal pain—Hydrocortisone—ulcerative colitis	7.02e-05	0.00133	CcSEcCtD
Procainamide—Convulsion—Prednisone—ulcerative colitis	7.01e-05	0.00133	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Triamcinolone—ulcerative colitis	6.93e-05	0.0358	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Triamcinolone—ulcerative colitis	6.93e-05	0.0358	CbGdCrCtD
Procainamide—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.91e-05	0.00131	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.91e-05	0.00131	CcSEcCtD
Procainamide—Myalgia—Prednisone—ulcerative colitis	6.89e-05	0.0013	CcSEcCtD
Procainamide—Arthralgia—Prednisone—ulcerative colitis	6.89e-05	0.0013	CcSEcCtD
Procainamide—Feeling abnormal—Triamcinolone—ulcerative colitis	6.89e-05	0.0013	CcSEcCtD
Procainamide—Feeling abnormal—Methylprednisolone—ulcerative colitis	6.87e-05	0.0013	CcSEcCtD
Procainamide—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.82e-05	0.00129	CcSEcCtD
Procainamide—Discomfort—Prednisone—ulcerative colitis	6.81e-05	0.00129	CcSEcCtD
Procainamide—Hypersensitivity—Prednisolone—ulcerative colitis	6.7e-05	0.00127	CcSEcCtD
Procainamide—Urticaria—Triamcinolone—ulcerative colitis	6.64e-05	0.00125	CcSEcCtD
Procainamide—Urticaria—Methylprednisolone—ulcerative colitis	6.62e-05	0.00125	CcSEcCtD
Procainamide—Body temperature increased—Triamcinolone—ulcerative colitis	6.61e-05	0.00125	CcSEcCtD
Procainamide—Abdominal pain—Methylprednisolone—ulcerative colitis	6.59e-05	0.00125	CcSEcCtD
Procainamide—Decreased appetite—Dexamethasone—ulcerative colitis	6.59e-05	0.00125	CcSEcCtD
Procainamide—Decreased appetite—Betamethasone—ulcerative colitis	6.59e-05	0.00125	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisone—ulcerative colitis	6.57e-05	0.034	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisone—ulcerative colitis	6.57e-05	0.034	CbGdCrCtD
Procainamide—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.54e-05	0.00124	CcSEcCtD
Procainamide—Shock—Prednisone—ulcerative colitis	6.5e-05	0.00123	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisolone—ulcerative colitis	6.42e-05	0.0332	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisolone—ulcerative colitis	6.42e-05	0.0332	CbGdCrCtD
Procainamide—Asthenia—Hydrocortisone—ulcerative colitis	6.37e-05	0.0012	CcSEcCtD
Procainamide—Anorexia—Prednisone—ulcerative colitis	6.29e-05	0.00119	CcSEcCtD
Procainamide—Pruritus—Hydrocortisone—ulcerative colitis	6.28e-05	0.00119	CcSEcCtD
Procainamide—Feeling abnormal—Betamethasone—ulcerative colitis	6.25e-05	0.00118	CcSEcCtD
Procainamide—Feeling abnormal—Dexamethasone—ulcerative colitis	6.25e-05	0.00118	CcSEcCtD
Procainamide—Gastrointestinal pain—Dexamethasone—ulcerative colitis	6.2e-05	0.00117	CcSEcCtD
Procainamide—Gastrointestinal pain—Betamethasone—ulcerative colitis	6.2e-05	0.00117	CcSEcCtD
Procainamide—Hypersensitivity—Triamcinolone—ulcerative colitis	6.16e-05	0.00116	CcSEcCtD
Procainamide—Hypersensitivity—Methylprednisolone—ulcerative colitis	6.14e-05	0.00116	CcSEcCtD
Procainamide—Diarrhoea—Hydrocortisone—ulcerative colitis	6.07e-05	0.00115	CcSEcCtD
Procainamide—Urticaria—Betamethasone—ulcerative colitis	6.02e-05	0.00114	CcSEcCtD
Procainamide—Urticaria—Dexamethasone—ulcerative colitis	6.02e-05	0.00114	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Prednisone—ulcerative colitis	6.02e-05	0.00114	CcSEcCtD
Procainamide—Dizziness—Prednisolone—ulcerative colitis	6.01e-05	0.00114	CcSEcCtD
Procainamide—Asthenia—Triamcinolone—ulcerative colitis	6e-05	0.00113	CcSEcCtD
Procainamide—Abdominal pain—Dexamethasone—ulcerative colitis	5.99e-05	0.00113	CcSEcCtD
Procainamide—Abdominal pain—Betamethasone—ulcerative colitis	5.99e-05	0.00113	CcSEcCtD
Procainamide—Body temperature increased—Betamethasone—ulcerative colitis	5.99e-05	0.00113	CcSEcCtD
Procainamide—Body temperature increased—Dexamethasone—ulcerative colitis	5.99e-05	0.00113	CcSEcCtD
Procainamide—Asthenia—Methylprednisolone—ulcerative colitis	5.98e-05	0.00113	CcSEcCtD
Procainamide—Pruritus—Triamcinolone—ulcerative colitis	5.91e-05	0.00112	CcSEcCtD
Procainamide—Pruritus—Methylprednisolone—ulcerative colitis	5.9e-05	0.00112	CcSEcCtD
Procainamide—Sunitinib—ABCB1—ulcerative colitis	5.88e-05	0.019	CrCbGaD
Procainamide—Dizziness—Hydrocortisone—ulcerative colitis	5.87e-05	0.00111	CcSEcCtD
Procainamide—Decreased appetite—Prednisone—ulcerative colitis	5.74e-05	0.00109	CcSEcCtD
Procainamide—Diarrhoea—Methylprednisolone—ulcerative colitis	5.71e-05	0.00108	CcSEcCtD
Procainamide—Vomiting—Hydrocortisone—ulcerative colitis	5.64e-05	0.00107	CcSEcCtD
Procainamide—Dizziness—Triamcinolone—ulcerative colitis	5.53e-05	0.00104	CcSEcCtD
Procainamide—Dizziness—Methylprednisolone—ulcerative colitis	5.51e-05	0.00104	CcSEcCtD
Procainamide—Feeling abnormal—Prednisone—ulcerative colitis	5.44e-05	0.00103	CcSEcCtD
Procainamide—Asthenia—Betamethasone—ulcerative colitis	5.44e-05	0.00103	CcSEcCtD
Procainamide—Asthenia—Dexamethasone—ulcerative colitis	5.44e-05	0.00103	CcSEcCtD
Procainamide—Gastrointestinal pain—Prednisone—ulcerative colitis	5.4e-05	0.00102	CcSEcCtD
Procainamide—Nausea—Prednisolone—ulcerative colitis	5.4e-05	0.00102	CcSEcCtD
Procainamide—Pruritus—Dexamethasone—ulcerative colitis	5.36e-05	0.00101	CcSEcCtD
Procainamide—Pruritus—Betamethasone—ulcerative colitis	5.36e-05	0.00101	CcSEcCtD
Procainamide—Vomiting—Triamcinolone—ulcerative colitis	5.31e-05	0.001	CcSEcCtD
Procainamide—Vomiting—Methylprednisolone—ulcerative colitis	5.3e-05	0.001	CcSEcCtD
Procainamide—Nausea—Hydrocortisone—ulcerative colitis	5.27e-05	0.000996	CcSEcCtD
Procainamide—Urticaria—Prednisone—ulcerative colitis	5.25e-05	0.000992	CcSEcCtD
Procainamide—Body temperature increased—Prednisone—ulcerative colitis	5.22e-05	0.000987	CcSEcCtD
Procainamide—Abdominal pain—Prednisone—ulcerative colitis	5.22e-05	0.000987	CcSEcCtD
Procainamide—Diarrhoea—Dexamethasone—ulcerative colitis	5.19e-05	0.000981	CcSEcCtD
Procainamide—Diarrhoea—Betamethasone—ulcerative colitis	5.19e-05	0.000981	CcSEcCtD
Procainamide—Dizziness—Dexamethasone—ulcerative colitis	5.01e-05	0.000948	CcSEcCtD
Procainamide—Dizziness—Betamethasone—ulcerative colitis	5.01e-05	0.000948	CcSEcCtD
Procainamide—Nausea—Triamcinolone—ulcerative colitis	4.96e-05	0.000938	CcSEcCtD
Procainamide—Nausea—Methylprednisolone—ulcerative colitis	4.95e-05	0.000936	CcSEcCtD
Procainamide—Hypersensitivity—Prednisone—ulcerative colitis	4.87e-05	0.00092	CcSEcCtD
Procainamide—Vomiting—Betamethasone—ulcerative colitis	4.82e-05	0.000911	CcSEcCtD
Procainamide—Vomiting—Dexamethasone—ulcerative colitis	4.82e-05	0.000911	CcSEcCtD
Procainamide—Asthenia—Prednisone—ulcerative colitis	4.74e-05	0.000896	CcSEcCtD
Procainamide—Pruritus—Prednisone—ulcerative colitis	4.67e-05	0.000883	CcSEcCtD
Procainamide—Diarrhoea—Prednisone—ulcerative colitis	4.52e-05	0.000854	CcSEcCtD
Procainamide—Nausea—Betamethasone—ulcerative colitis	4.5e-05	0.000851	CcSEcCtD
Procainamide—Nausea—Dexamethasone—ulcerative colitis	4.5e-05	0.000851	CcSEcCtD
Procainamide—Dizziness—Prednisone—ulcerative colitis	4.37e-05	0.000825	CcSEcCtD
Procainamide—Vomiting—Prednisone—ulcerative colitis	4.2e-05	0.000794	CcSEcCtD
Procainamide—Nausea—Prednisone—ulcerative colitis	3.92e-05	0.000741	CcSEcCtD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.46e-05	0.000505	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	2.45e-05	0.000503	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—ALB—ulcerative colitis	2.44e-05	0.000501	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—ADCY5—ulcerative colitis	2.43e-05	0.000497	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MMP9—ulcerative colitis	2.41e-05	0.000495	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MMP9—ulcerative colitis	2.41e-05	0.000495	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCR2—ulcerative colitis	2.41e-05	0.000494	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—PPARG—ulcerative colitis	2.41e-05	0.000493	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—PPARG—ulcerative colitis	2.41e-05	0.000493	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	2.4e-05	0.000492	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.35e-05	0.000483	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TGFB1—ulcerative colitis	2.34e-05	0.00048	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MMP9—ulcerative colitis	2.33e-05	0.000477	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MMP9—ulcerative colitis	2.33e-05	0.000477	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	2.32e-05	0.000475	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MMP9—ulcerative colitis	2.32e-05	0.000475	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—NFKB1—ulcerative colitis	2.29e-05	0.00047	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—VDR—ulcerative colitis	2.29e-05	0.00047	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—JAK2—ulcerative colitis	2.27e-05	0.000465	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCR6—ulcerative colitis	2.27e-05	0.000465	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TNF—ulcerative colitis	2.26e-05	0.000463	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—STAT3—ulcerative colitis	2.25e-05	0.000462	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CHP1—ulcerative colitis	2.24e-05	0.00046	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—IL6—ulcerative colitis	2.2e-05	0.000452	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—RELA—ulcerative colitis	2.2e-05	0.000451	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TNF—ulcerative colitis	2.19e-05	0.000448	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—JAK2—ulcerative colitis	2.17e-05	0.000445	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.17e-05	0.000445	CbGpPWpGaD
Procainamide—ACHE—Metabolism—DLD—ulcerative colitis	2.17e-05	0.000445	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—ADCY5—ulcerative colitis	2.17e-05	0.000444	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.16e-05	0.000443	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—ADCY5—ulcerative colitis	2.12e-05	0.000435	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—RELA—ulcerative colitis	2.1e-05	0.000431	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.1e-05	0.000431	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TGFB1—ulcerative colitis	2.09e-05	0.000428	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—JAK2—ulcerative colitis	2.09e-05	0.000428	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—JAK2—ulcerative colitis	2.09e-05	0.000428	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—STAT3—ulcerative colitis	2.06e-05	0.000422	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.02e-05	0.000415	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—RELA—ulcerative colitis	2.02e-05	0.000414	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—RELA—ulcerative colitis	2.02e-05	0.000414	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—ADCY5—ulcerative colitis	2.02e-05	0.000414	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—IL6—ulcerative colitis	2.02e-05	0.000413	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—JAK2—ulcerative colitis	2.01e-05	0.000412	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—JAK2—ulcerative colitis	2.01e-05	0.000412	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CHP1—ulcerative colitis	2e-05	0.00041	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—PTGER4—ulcerative colitis	1.99e-05	0.000409	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.99e-05	0.000408	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	1.99e-05	0.000407	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.98e-05	0.000407	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—JAK2—ulcerative colitis	1.98e-05	0.000406	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TNF—ulcerative colitis	1.95e-05	0.0004	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—RELA—ulcerative colitis	1.95e-05	0.000399	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—RELA—ulcerative colitis	1.95e-05	0.000399	CbGpPWpGaD
Procainamide—BCHE—Metabolism—DLD—ulcerative colitis	1.93e-05	0.000397	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TGFB1—ulcerative colitis	1.91e-05	0.000392	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—GHRL—ulcerative colitis	1.89e-05	0.000388	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.88e-05	0.000384	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MMP9—ulcerative colitis	1.87e-05	0.000384	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CHP1—ulcerative colitis	1.87e-05	0.000383	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.86e-05	0.000381	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—NFKB1—ulcerative colitis	1.85e-05	0.00038	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.85e-05	0.00038	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—GHRL—ulcerative colitis	1.83e-05	0.000374	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.82e-05	0.000374	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MMP9—ulcerative colitis	1.79e-05	0.000367	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TNF—ulcerative colitis	1.78e-05	0.000366	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—NFKB1—ulcerative colitis	1.77e-05	0.000364	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—IL6—ulcerative colitis	1.77e-05	0.000362	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCR1—ulcerative colitis	1.74e-05	0.000357	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—DLD—ulcerative colitis	1.73e-05	0.000354	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MMP9—ulcerative colitis	1.72e-05	0.000353	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MMP9—ulcerative colitis	1.72e-05	0.000353	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—NFKB1—ulcerative colitis	1.7e-05	0.000349	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—NFKB1—ulcerative colitis	1.7e-05	0.000349	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—PPARG—ulcerative colitis	1.69e-05	0.000347	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—GHRL—ulcerative colitis	1.69e-05	0.000346	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	1.67e-05	0.000343	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—STAT3—ulcerative colitis	1.67e-05	0.000342	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MMP9—ulcerative colitis	1.66e-05	0.00034	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MMP9—ulcerative colitis	1.66e-05	0.00034	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.65e-05	0.000339	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—NFKB1—ulcerative colitis	1.64e-05	0.000337	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—NFKB1—ulcerative colitis	1.64e-05	0.000337	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MMP9—ulcerative colitis	1.64e-05	0.000335	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—IL6—ulcerative colitis	1.63e-05	0.000334	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—DLD—ulcerative colitis	1.61e-05	0.00033	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	1.61e-05	0.000329	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—PPARG—ulcerative colitis	1.6e-05	0.000327	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—STAT3—ulcerative colitis	1.59e-05	0.000327	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCR1—ulcerative colitis	1.58e-05	0.000324	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—IL6—ulcerative colitis	1.57e-05	0.000323	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.56e-05	0.00032	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—IL6—ulcerative colitis	1.56e-05	0.00032	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TGFB1—ulcerative colitis	1.54e-05	0.000317	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.54e-05	0.000315	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—STAT3—ulcerative colitis	1.53e-05	0.000314	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—STAT3—ulcerative colitis	1.53e-05	0.000314	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCL20—ulcerative colitis	1.53e-05	0.000313	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—ADRB2—ulcerative colitis	1.51e-05	0.00031	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—IL6—ulcerative colitis	1.5e-05	0.000307	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—IL6—ulcerative colitis	1.5e-05	0.000307	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	1.5e-05	0.000307	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TGFB1—ulcerative colitis	1.48e-05	0.000303	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—STAT3—ulcerative colitis	1.48e-05	0.000303	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—STAT3—ulcerative colitis	1.48e-05	0.000303	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.46e-05	0.000299	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—IL6—ulcerative colitis	1.44e-05	0.000296	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—IL6—ulcerative colitis	1.44e-05	0.000296	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—ulcerative colitis	1.44e-05	0.000296	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—IL6—ulcerative colitis	1.44e-05	0.000295	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNA12—ulcerative colitis	1.44e-05	0.000295	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.43e-05	0.000294	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TGFB1—ulcerative colitis	1.42e-05	0.000291	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TGFB1—ulcerative colitis	1.42e-05	0.000291	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—JAK2—ulcerative colitis	1.41e-05	0.00029	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL20—ulcerative colitis	1.39e-05	0.000285	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—ulcerative colitis	1.38e-05	0.000283	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—RELA—ulcerative colitis	1.37e-05	0.000281	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TGFB1—ulcerative colitis	1.37e-05	0.000281	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TGFB1—ulcerative colitis	1.37e-05	0.000281	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCR2—ulcerative colitis	1.36e-05	0.000279	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS1—ulcerative colitis	1.33e-05	0.000273	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—ulcerative colitis	1.33e-05	0.000272	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—ulcerative colitis	1.33e-05	0.000272	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNA12—ulcerative colitis	1.3e-05	0.000268	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.29e-05	0.000264	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR6—ulcerative colitis	1.28e-05	0.000263	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—ulcerative colitis	1.28e-05	0.000262	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—ulcerative colitis	1.28e-05	0.000262	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.25e-05	0.000256	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.25e-05	0.000255	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.24e-05	0.000255	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCR2—ulcerative colitis	1.24e-05	0.000254	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.21e-05	0.000247	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CALM3—ulcerative colitis	1.2e-05	0.000246	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP1—ulcerative colitis	1.18e-05	0.000241	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP9—ulcerative colitis	1.17e-05	0.000239	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	1.17e-05	0.000239	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.17e-05	0.000239	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.16e-05	0.000239	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—IL6—ulcerative colitis	1.16e-05	0.000239	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR6—ulcerative colitis	1.16e-05	0.000238	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—NFKB1—ulcerative colitis	1.15e-05	0.000237	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.15e-05	0.000235	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SEL1L—ulcerative colitis	1.13e-05	0.000232	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PTGER4—ulcerative colitis	1.13e-05	0.000231	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—ulcerative colitis	1.11e-05	0.000228	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.09e-05	0.000223	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—ulcerative colitis	1.07e-05	0.000219	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—ulcerative colitis	1.07e-05	0.000219	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP1—ulcerative colitis	1.05e-05	0.000215	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS1—ulcerative colitis	1.05e-05	0.000215	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—STAT3—ulcerative colitis	1.04e-05	0.000213	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GHRL—ulcerative colitis	1.03e-05	0.000212	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.03e-05	0.000211	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—ulcerative colitis	1.03e-05	0.000211	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—ulcerative colitis	1.03e-05	0.000211	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.03e-05	0.000211	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PTGER4—ulcerative colitis	1.02e-05	0.00021	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.02e-05	0.00021	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—ulcerative colitis	1.02e-05	0.000208	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—ulcerative colitis	9.62e-06	0.000197	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	9.59e-06	0.000197	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CALM3—ulcerative colitis	9.44e-06	0.000194	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	9.4e-06	0.000193	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GHRL—ulcerative colitis	9.37e-06	0.000192	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS1—ulcerative colitis	9.35e-06	0.000192	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCR1—ulcerative colitis	9.34e-06	0.000191	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ABCB1—ulcerative colitis	9.33e-06	0.000191	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.2e-06	0.000189	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CALM3—ulcerative colitis	9.08e-06	0.000186	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.02e-06	0.000185	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—ulcerative colitis	8.98e-06	0.000184	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—DLD—ulcerative colitis	8.9e-06	0.000182	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ADCY5—ulcerative colitis	8.7e-06	0.000178	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADRB2—ulcerative colitis	8.54e-06	0.000175	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CALM3—ulcerative colitis	8.42e-06	0.000173	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS1—ulcerative colitis	8.35e-06	0.000171	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL20—ulcerative colitis	8.2e-06	0.000168	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.05e-06	0.000165	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.81e-06	0.00016	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS1—ulcerative colitis	7.79e-06	0.00016	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADRB2—ulcerative colitis	7.76e-06	0.000159	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNA12—ulcerative colitis	7.71e-06	0.000158	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CXCL8—ulcerative colitis	7.56e-06	0.000155	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CALM3—ulcerative colitis	7.52e-06	0.000154	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCB1—ulcerative colitis	7.34e-06	0.000151	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCR2—ulcerative colitis	7.31e-06	0.00015	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL8—ulcerative colitis	7.3e-06	0.00015	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.28e-06	0.000149	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADCY5—ulcerative colitis	7.25e-06	0.000149	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—ulcerative colitis	7.25e-06	0.000149	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CALM3—ulcerative colitis	7.01e-06	0.000144	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR6—ulcerative colitis	6.87e-06	0.000141	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADCY5—ulcerative colitis	6.85e-06	0.00014	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CXCL8—ulcerative colitis	6.75e-06	0.000138	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADCY5—ulcerative colitis	6.59e-06	0.000135	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCB1—ulcerative colitis	6.55e-06	0.000134	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAML2—ulcerative colitis	6.51e-06	0.000134	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—ulcerative colitis	6.49e-06	0.000133	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADCY5—ulcerative colitis	6.11e-06	0.000125	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTGER4—ulcerative colitis	6.05e-06	0.000124	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCB1—ulcerative colitis	5.85e-06	0.00012	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—ulcerative colitis	5.83e-06	0.00012	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GHRL—ulcerative colitis	5.54e-06	0.000114	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADCY5—ulcerative colitis	5.46e-06	0.000112	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCB1—ulcerative colitis	5.45e-06	0.000112	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CALM3—ulcerative colitis	5.36e-06	0.00011	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RIPK2—ulcerative colitis	5.28e-06	0.000108	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—ulcerative colitis	5.11e-06	0.000105	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—ulcerative colitis	5.1e-06	0.000105	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADCY5—ulcerative colitis	5.09e-06	0.000104	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—ulcerative colitis	4.59e-06	9.42e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB2—ulcerative colitis	4.58e-06	9.4e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—ulcerative colitis	4.56e-06	9.34e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—JAK2—ulcerative colitis	4.52e-06	9.27e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS1—ulcerative colitis	4.3e-06	8.82e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL8—ulcerative colitis	4.13e-06	8.46e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—JAK2—ulcerative colitis	4.11e-06	8.42e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—ulcerative colitis	4.1e-06	8.4e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—ulcerative colitis	4.07e-06	8.34e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—ulcerative colitis	4.02e-06	8.24e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—ulcerative colitis	3.94e-06	8.09e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADCY5—ulcerative colitis	3.89e-06	7.98e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CALM3—ulcerative colitis	3.87e-06	7.94e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—ulcerative colitis	3.79e-06	7.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL8—ulcerative colitis	3.75e-06	7.68e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—ulcerative colitis	3.66e-06	7.5e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—ulcerative colitis	3.58e-06	7.35e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—ulcerative colitis	3.58e-06	7.34e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—ulcerative colitis	3.41e-06	6.99e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—ulcerative colitis	3.2e-06	6.56e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCB1—ulcerative colitis	3.01e-06	6.17e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—ulcerative colitis	2.98e-06	6.12e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.81e-06	5.76e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JAK2—ulcerative colitis	2.43e-06	4.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RELA—ulcerative colitis	2.35e-06	4.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL8—ulcerative colitis	2.21e-06	4.54e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—ulcerative colitis	2.12e-06	4.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—ulcerative colitis	2.1e-06	4.32e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.1e-06	4.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—ulcerative colitis	2e-06	4.11e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NFKB1—ulcerative colitis	1.98e-06	4.06e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—ulcerative colitis	1.88e-06	3.86e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—ulcerative colitis	1.78e-06	3.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—ulcerative colitis	1.65e-06	3.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.65e-06	3.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—ulcerative colitis	1.36e-06	2.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—ulcerative colitis	1.24e-06	2.55e-05	CbGpPWpGaD
